Machiko Kai

Proteomic analysis of serum extracellular vesicles reveals Fibulin-3 as a new marker predicting liver-related events in MASLD.

E. Morii, T. Kodama, Kazuhiro Murai, 2024, Hepatology communications.

Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational study

N. Hiramatsu, K. Imanaka, K. Ohkawa, 2024, PloS one.